அலெக்ஸ் டசல்ல News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அலெக்ஸ் டசல்ல. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அலெக்ஸ் டசல்ல Today - Breaking & Trending Today

Collegium Pharmaceutical, inc (COLL) Q2 2021 Earnings Call Transcript

Collegium Pharmaceutical, inc (COLL) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

Oren Livnat , Scott Dreyer , David Steinberg , Pauline Tupper , Joe Ciaffoni , Greg Fraser Truist , Alex Dasalla , Tim Lugo William Blair , Piper Sandler , Tim Lugo , Greg Fraser , David Amsellem , David Amsellem Piper Sandler , Brandon Folkes , William Blair , David Steinberg Jefferies , Exchange Commission , Welcome To Collegium Pharmaceuticals Second Quarter , Cantor Fitzgerald , Corporate Communications , Collegium Pharmaceutical , Collegium Pharmaceutical Second Quarter , Investor Relations , Collegium Pharmaceuticals Second Quarter , Collegiumi M , Chief Executive Officer ,

Collegium Pharmaceutical Inc (COLL) Q1 2021 Earnings Call Transcript

Operator
Greetings, and welcome to the Collegium Pharmaceutical First Quarter 2021 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Alex Dasalla. Please go ahead.
Alex Dasalla
Head of Investor Relations
Welcome to Collegium Pharmaceuticals first quarter 2021 earnings conference call. This is Alex Dasalla, Head of Investor Relations for Collegium. I am joined today by Joe Ciaffoni, our Chief Executive Officer; Paul Brannelly, our Chief Financial Officer; and Scott Dreyer, our Chief Commercial Officer.
Before we begin today s call, we want to remind participants that none of the information presented today is intended to be promotional and that any forward-looking statements made today are made pursuant to the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995. You are cautioned that such forward-looking statements involve risks and uncertaintie ....

United States , Scott Dreyer , Brandon Folkes Cantor Fitzgerald , David Steinberg , Joe Ciaffoni , Paul Brannelly , Serge Belanger , Alex Dasalla , Tim Lugo William Blair , Piper Sandler , Colleen Tupper , Gregg Gilbert , Tim Lugo , David Amsellem , David Amsellem Piper Sandler , Serge Belanger Needham , Gregg Gilbert Truist , Brandon Folkes , Joseph Ciaffoni , William Blair , David Steinberg Jefferies , Exchange Commission , Collegium Pharmaceutical Inc , Cantor Fitzgerald , Welcome To Collegium Pharmaceuticals , Thermo Fisher ,

Collegium Pharmaceutical Inc (COLL) Q4 2020 Earnings Call Transcript

Collegium Pharmaceutical Inc (COLL) Q4 2020 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

United States , Alex Dasalla , Lachlan Hanbury Brown William Blair , Scott Dreyer , David Amsellem Piper Jaffray , Tim Lugo , David Amsellem , Joe Ciaffoni , Paul Brannelly , William Blair , Exchange Commission , Collegium Pharmaceutical Inc , Welcome To Collegium Pharmaceuticals , Piper Jaffray , Collegium Pharmaceutical Fourth Quarter , Investor Relations , Collegium Pharmaceuticals , Chief Executive Officer , Chief Financial Officer , Chief Commercial , Safe Harbor , Private Securities Litigation Reform Act , Chief Executive , Teva Xtampza , Life Science Cares , Vice President ,

Collegium Provides 2021 Financial Guidance

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Collegium Provides 2021 Financial Guidance
Collegium Pharmaceutical, Inc.January 6, 2021 GMT
– Xtampza
– Nucynta
– Adjusted EBITDA Expected in the Range of $160.0 million to $170.0 million –
STOUGHTON, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced its 2021 full-year financial guidance.
ADVERTISEMENT
“Collegium achieved a financially transformative year in 2020, driven by Xtampza ER growth and the acquisition of the Nucynta franchise. We delivered on our broad operational objectives and prioritized the health and safety of our people, customers and the communities that we serve,” said Joe Ciaffoni, President and Chief Executive Officer of Collegium. “As we head into 2021, we remain steadfa ....

United States , Alex Dasalla , Joe Ciaffoni , Paul Brannelly , Collegium Pharmaceutical Inc , Purdue Pharma , Us Drug Enforcement Agency , Franchise Revenues Expected , Collegium Pharmaceutical , Chief Executive Officer , Executive Vice President , Chief Financial Officer , Private Securities Litigation Reform Act , Nucynta Franchise , Enforcement Agency , Quarterly Report , ஒன்றுபட்டது மாநிலங்களில் , அலெக்ஸ் டசல்ல , கல்லூரி மருந்து இன்க் , பர்‌ட்யூ பார்மா , உரிமையை வருவாய் எதிர்பார்க்கப்படுகிறது , கல்லூரி மருந்து , தலைமை நிர்வாகி அதிகாரி , நிர்வாகி துணை ப்ரெஸிடெஂட் , தலைமை நிதி அதிகாரி , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,